| Bid Price | 2.35p | High Price | 2.49p |
|---|
| Ask Price | 2.45p | Low Price | 2.35p |
|---|
| Open Price | 2.45p | Spread | 4.08% |
|---|
| Prev Close | 2.45p | Volume | 2,767,252 |
|---|
Genedrive PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Nov 22, 2024 | 2.45 | 2.49 | 2.35 | 2.40 | 2,767,252 |
| Nov 21, 2024 | 2.40 | 2.80 | 2.30 | 2.45 | 18,419,832 |
| Nov 20, 2024 | 2.33 | 2.50 | 2.25 | 2.40 | 7,490,283 |
| Nov 19, 2024 | 2.40 | 2.45 | 2.23 | 2.33 | 3,117,180 |
| Nov 18, 2024 | 2.38 | 2.44 | 2.30 | 2.40 | 3,017,642 |
Genedrive PLC Information
| Name | Genedrive PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00B1VKB244 | Epic | GDR |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Diagnostics & Research | Sector | Healthcare |
|---|
| EMS | 50,000 | Trading Status | Closed |
|---|
| Shares in Issue | 543.14 m | Prev Close | 2.45p |
|---|
| PE Ratio | | Market Cap | £13.04 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.02 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -1.045461 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 1.634765 | Quick Ratio | 0.744956 |
|---|
Genedrive PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 15/08/24 | BUY | Ian Gilham | CH | 1,000,000 @ £0.03 | £31,000.00 |
| 15/05/24 | PLAC | Thomas Lindsay | NED | 666,666 @ £0.02 | £10,000.00 |
| 15/05/24 | PLAC | James Cheek | CEO | 666,666 @ £0.02 | £10,000.00 |
| 23/02/22 | SELL | Matthew Fowler | RES | 86,957 @ £0.18 | £15,217.00 |
| 01/10/21 | PLAC | Ian Gilham | CH | 80,000 @ £0.25 | £20,000.00 |
| 01/10/21 | PLAC | Chris Yates | NED | 20,000 @ £0.25 | £5,000.00 |
| 01/10/21 | PLAC | David Budd | RES | 80,000 @ £0.25 | £20,000.00 |
| 01/10/21 | PLAC | Matthew Fowler | RES | 40,000 @ £0.25 | £10,000.00 |
| 01/10/21 | PLAC | Thomas Lindsay | NED | 60,000 @ £0.25 | £15,000.00 |
| 12/05/20 | PLAC | Ian Gilham | CH | 12,500 @ £0.80 | £10,000.00 |
Genedrive PLC News
